Edwards Lifesciences EBITDA 2010-2025 | EW

Edwards Lifesciences annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Edwards Lifesciences EBITDA for the quarter ending March 31, 2025 was $0.431B, a 11.33% increase year-over-year.
  • Edwards Lifesciences EBITDA for the twelve months ending March 31, 2025 was $1.578B, a 11.29% increase year-over-year.
  • Edwards Lifesciences 2024 annual EBITDA was $1.534B, a 5.51% increase from 2023.
  • Edwards Lifesciences 2023 annual EBITDA was $1.454B, a 11.25% decline from 2022.
  • Edwards Lifesciences 2022 annual EBITDA was $1.638B, a 10.25% decline from 2021.
Edwards Lifesciences Annual EBITDA
(Millions of US $)
2024 $1,534
2023 $1,454
2022 $1,638
2021 $1,825
2020 $1,005
2019 $1,236
2018 $826
2017 $1,171
2016 $855
2015 $709
2014 $561
2013 $535
2012 $474
2011 $358
2010 $341
2009 $297
Edwards Lifesciences Quarterly EBITDA
(Millions of US $)
2025-03-31 $431
2024-12-31 $353
2024-09-30 $385
2024-06-30 $409
2024-03-31 $388
2023-12-31 $328
2023-09-30 $403
2023-06-30 $300
2023-03-31 $424
2022-12-31 $233
2022-09-30 $438
2022-06-30 $494
2022-03-31 $474
2021-12-31 $407
2021-09-30 $424
2021-06-30 $578
2021-03-31 $416
2020-12-31 $384
2020-09-30 $383
2020-06-30 $-145
2020-03-31 $383
2019-12-31 $335
2019-09-30 $317
2019-06-30 $289
2019-03-31 $295
2018-12-31 $15
2018-09-30 $268
2018-06-30 $271
2018-03-31 $272
2017-12-31 $326
2017-09-30 $248
2017-06-30 $268
2017-03-31 $330
2016-12-31 $191
2016-09-30 $214
2016-06-30 $233
2016-03-31 $218
2015-12-31 $189
2015-09-30 $174
2015-06-30 $164
2015-03-31 $181
2014-12-31 $169
2014-09-30 $148
2014-06-30 $135
2014-03-31 $110
2013-12-31 $145
2013-09-30 $123
2013-06-30 $141
2013-03-31 $126
2012-12-31 $155
2012-09-30 $109
2012-06-30 $110
2012-03-31 $100
2011-12-31 $101
2011-09-30 $74
2011-06-30 $90
2011-03-31 $93
2010-12-31 $96
2010-09-30 $81
2010-06-30 $87
2010-03-31 $77
2009-12-31 $79
2009-09-30 $72
2009-06-30 $77
2009-03-31 $69
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $45.884B $5.440B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $197.969B 86.71
Thermo Fisher Scientific (TMO) United States $152.062B 18.39
Alcon (ALC) Switzerland $42.389B 28.65
IDEXX Laboratories (IDXX) United States $41.285B 47.45
DexCom (DXCM) United States $33.643B 52.00
IQVIA Holdings (IQV) United States $24.277B 13.60
STERIS (STE) Ireland $24.092B 26.57
Mettler-Toledo (MTD) United States $24.015B 28.56
Waters (WAT) United States $20.783B 29.32
SONOVA HOLDING (SONVY) Switzerland $18.675B 0.00
Hologic (HOLX) United States $13.854B 15.05
Sysmex ADR (SSMXY) Japan $10.550B 29.93
Penumbra (PEN) United States $10.339B 81.15
Masimo (MASI) United States $8.811B 32.50
Globus Medical (GMED) United States $8.012B 19.09
Teleflex (TFX) United States $5.403B 8.92
Glaukos (GKOS) United States $5.388B 0.00
TransMedics (TMDX) United States $4.300B 93.47
Integer Holdings (ITGR) United States $4.144B 21.71
PROCEPT BioRobotics (PRCT) United States $3.209B 0.00
LivaNova (LIVN) United Kingdom $2.358B 14.04
Veracyte (VCYT) United States $2.084B 29.24
Nihon Kohden (NHNKY) Japan $2.062B 23.65
Elekta AB (EKTAY) Sweden $1.996B 17.94
Alphatec Holdings (ATEC) United States $1.817B 0.00
Tandem Diabetes Care (TNDM) United States $1.320B 0.00
Artivion (AORT) United States $1.263B 118.32
Pulse Biosciences (PLSE) United States $1.164B 0.00
OPKO Health (OPK) United States $1.079B 0.00
Integra LifeSciences Holdings (IART) United States $0.984B 5.23
SiBone (SIBN) United States $0.805B 0.00
Beta Bionics (BBNX) United States $0.747B 0.00
IRadimed (IRMD) United States $0.736B 37.34
RxSight (RXST) United States $0.621B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.581B 9.04
Delcath Systems (DCTH) United States $0.565B 0.00
Mesa Laboratories (MLAB) United States $0.549B 12.87
AxoGen (AXGN) United States $0.496B 0.00
OrthoPediatrics (KIDS) United States $0.485B 0.00
Semler Scientific (SMLR) United States $0.446B 11.87
ORTHOFIX MEDICAL INC (OFIX) United States $0.441B 0.00
NeuroPace (NPCE) United States $0.434B 0.00
AngioDynamics (ANGO) United States $0.414B 0.00
Treace Medical Concepts (TMCI) United States $0.361B 0.00
ClearPoint Neuro (CLPT) United States $0.331B 0.00
Pacific Biosciences Of California (PACB) United States $0.289B 0.00
Neuronetics (STIM) United States $0.257B 0.00
Tactile Systems Technology (TCMD) United States $0.230B 13.92
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
908 Devices (MASS) United States $0.204B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Spectral Diagnostics (EDTXF) Canada $0.176B 0.00
CVRx (CVRX) United States $0.173B 0.00
Inogen (INGN) United States $0.173B 0.00
LENSAR (LNSR) United States $0.160B 0.00
Accuray (ARAY) United States $0.158B 0.00
Anteris Technologies Global (AVR) Australia $0.153B 0.00
Biosig Technologies (BSGM) United States $0.153B 0.00
Lucid Diagnostics (LUCD) United States $0.150B 0.00
Rapid Micro Biosystems (RPID) United States $0.146B 0.00
Atossa Genetics (ATOS) United States $0.100B 0.00
Microbot Medical (MBOT) United States $0.092B 0.00
Monogram Orthopaedics (MGRM) United States $0.086B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
Sensus Healthcare (SRTS) United States $0.078B 47.60
EDAP TMS S.A (EDAP) France $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
Positron (POSC) United States $0.054B 0.00
Hyperfine (HYPR) United States $0.047B 0.00
Vicarious Surgical (RBOT) United States $0.045B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Baird Medical Investment Holdings (BDMD) $0.025B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
NexGel (NXGL) United States $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.23